NYSE:ALB - Albemarle Stock Price, News, & Analysis

Albemarle trades on the New York Stock Exchange (NYSE) under the ticker symbol "ALB."

Albemarle announced a quarterly dividend on Tuesday, February 26th. Investors of record on Friday, March 15th will be given a dividend of $0.3675 per share on Monday, April 1st. This represents a $1.47 annualized dividend and a dividend yield of 1.78%. The ex-dividend date is Thursday, March 14th. This is a positive change from Albemarle's previous quarterly dividend of $0.34. View Albemarle's Dividend History.

Albemarle Co. (NYSE:ALB) issued its quarterly earnings data on Wednesday, February, 20th. The specialty chemicals company reported $1.53 EPS for the quarter, beating analysts' consensus estimates of $1.46 by $0.07. The specialty chemicals company earned $921.70 million during the quarter, compared to the consensus estimate of $894.45 million. Albemarle had a net margin of 20.55% and a return on equity of 15.82%. The business's quarterly revenue was up 7.4% compared to the same quarter last year. During the same period in the prior year, the firm posted $1.34 EPS. View Albemarle's Earnings History.

Albemarle is scheduled to release their next quarterly earnings announcement on Wednesday, May 8th 2019. View Earnings Estimates for Albemarle.

Albemarle will be holding an earnings conference call on Thursday, May 9th at 9:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at 8443471034.

Albemarle issued an update on its FY19 earnings guidance on Wednesday, February, 20th. The company provided EPS guidance of $6.10-6.50 for the period, compared to the Thomson Reuters consensus estimate of $6.14. The company issued revenue guidance of $3.65-3.85 billion, compared to the consensus revenue estimate of $3.64 billion.Albemarle also updated its FY 2019 guidance to $6.10-6.50 EPS.

14 brokerages have issued 12 month price targets for Albemarle's shares. Their predictions range from $59.00 to $125.00. On average, they anticipate Albemarle's stock price to reach $97.6864 in the next twelve months. This suggests a possible upside of 18.5% from the stock's current price. View Analyst Price Targets for Albemarle.

14 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Albemarle in the last year. There are currently 2 sell ratings, 5 hold ratings and 7 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Albemarle.

News headlines about ALB stock have trended somewhat positive recently, according to InfoTrie. The research firm identifies positive and negative press coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of companies on a scale of negative five to five, with scores nearest to five being the most favorable. Albemarle earned a media sentiment score of 1.2 on InfoTrie's scale. They also gave news headlines about the specialty chemicals company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an effect on the company's share price in the immediate future.

Some companies that are related to Albemarle include Eastman Chemical (EMN), Hexcel (HXL), Sinopec Shanghai Petrochemical (SHI), Rogers (ROG), PolyOne (POL), Trinseo (TSE), Kraton (KRA), AdvanSix (ASIX), A Schulman (SHLM), Cereplast (CERPQ) and ForceField Energy (FNRG).

Based on aggregate information from My MarketBeat watchlists, some companies that other Albemarle investors own include Intact Financial (IFC), Constellation Software (CSU), AutoCanada (ACQ), Alimentation Couche-Tard (ATD.B), AbbVie (ABBV), Vermilion Energy (VET), Wheaton Precious Metals (WPM), Rogers Communications (RCI), Open Text (OTEX) and Valeant Pharmaceuticals Intl (VRX).

Albemarle's stock is owned by a variety of of institutional and retail investors. Top institutional investors include KAMES CAPITAL plc (0.45%), Scout Investments Inc. (0.23%), Rothschild Investment Corp IL (0.08%), Eastern Bank (0.06%), Retirement Systems of Alabama (0.05%) and Leavell Investment Management Inc. (0.04%). Company insiders that own Albemarle stock include Douglas L Maine, Karen G Narwold, Luther C Iv Kissam, Matthew Juneau and Scott Tozier. View Institutional Ownership Trends for Albemarle.

ALB stock was sold by a variety of institutional investors in the last quarter, including KAMES CAPITAL plc, Regent Investment Management LLC, DNB Asset Management AS, Harvey Capital Management Inc., Leavell Investment Management Inc., Retirement Systems of Alabama, Beech Hill Advisors Inc. and Sumitomo Life Insurance Co.. Company insiders that have sold Albemarle company stock in the last year include Karen G Narwold and Scott Tozier. View Insider Buying and Selling for Albemarle.

ALB stock was purchased by a variety of institutional investors in the last quarter, including Eastern Bank, Rothschild Investment Corp IL, Scout Investments Inc., QUANTRES ASSET MANAGEMENT Ltd, Bank of The West, Neville Rodie & Shaw Inc., Confluence Investment Management LLC and State of Alaska Department of Revenue. View Insider Buying and Selling for Albemarle.

Shares of ALB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of ALB stock can currently be purchased for approximately $82.44.

Albemarle has a market capitalization of $8.73 billion and generates $3.37 billion in revenue each year. The specialty chemicals company earns $693.56 million in net income (profit) each year or $5.48 on an earnings per share basis. Albemarle employs 5,900 workers across the globe.

The official website for Albemarle is http://www.albemarle.com.

Albemarle's mailing address is 4250 CONGRESS STREET SUITE 900, CHARLOTTE NC, 28209. The specialty chemicals company can be reached via phone at 980-299-5700 or via email at [email protected]